A study was conducted to identify and estimate the proportion of patients suffering from gonorrhoea, trichomoniasis, and candidosis, both with and without symptoms, seeking care or failing to seek care at all. Samples of women in a defined population were studied in antenatal, gynaecology, family planning, and sexually transmitted diseases clinics and in general practice. The incidence rates varied according to the conditions and to whether cases not proved microbiologically were included or excluded. The incidence rate may be less important than the prevalence rate since the former takes into account patients who have sought care whereas the latter is largely contributed by asymptomatic women who do not consult. The highest prevalence rates, in different agencies, were found for candidosis followed by trichomoniasis, with very low or zero rates for gonorrhoea.
Introduction
The routine published statistics for the sexually transmitted diseases are derived from the returns of cases treated made from clinics for sexually transmitted diseases in the United Kingdom each year. These are an underestimate of cases since they omit three categories of patients-those treated in general or private practice, or in antenatal and gynaecology clinics; symptomless patients who may never be treated; and patients with symptoms who decide to ignore them.
In the past, surveys carried out in the United Kingdom to calculate the amount of gonorrhoea, trichomoniasis, and candidosis found in gynaecology, antenatal, and family planning clinics'L-8 were limited to specific age groups and to patients who had opted to seek medical care, often for an unrelated condition. Since they refer only to one part of the total population of women at risk of contracting a sexually transmitted disease, these findings cannot be related to a defined population at risk, and correct incidence or prevalence rates cannot be obtained. In view of the potential shortfall in the current statistics, as outlined, and the ad-hoc nature of past surveys we studied the incidence and prevalence of gonorrhoea, trichomoniasis, and candidosis in a defined population of women.
Methods

PATIENTS AND SAMPLING
The study was designed to identify patients both with and without symptoms seeking care or failing to seek care at all. It was limited to women since in them sexually transmitted diseases are more often asymptomatic, and thus potentially untreated. Additionally, we envisaged considerable difficulty in obtaining a sample of asymptomatic men.
The different pathways that may be taken by a woman with sexually transmitted disease and the agencies sampled in the current study are shown in the figure. It was expected that patients with genital symptoms could seek care from general practitioners, sexually transmitted diseases clinics, or be referred to gynaecology clinics. In a three-month period in the gynaecology clinics 555 patients were screened. Of these, 75 had been referred with symptoms possibly due to a genital infection and were therefore included in the calculation of incidence; five were found to be suffering from candidosis, three from trichomoniasis, and one from gonorrhoea. If the consultation and disease rates were constant throughout the year, 20 cases of candidosis, 12 of trichomoniasis, and four of gonorrhoea would be identified in 12 months.
The final group of patients who contribute towards the incidence are those resident in the Brent and Harrow area seen in sexually transmitted diseases clinics both within and outside the area. During the whole of 1978, 182 cases of candidosis, 146 of trichomoniasis, and 136 of gonorrhoea were diagnosed among patients attending the one sexually transmitted diseases clinic within the study area. During the same year, the estimated numbers of cases arising from women resident in Brent and Harrow but seeking care in other London clinics were 520 of candidosis, 440 of gonorrhoea, and 320 of trichomoniasis.
The incidence rates per 1000 women aged 16-59 in Brent and Harrow vary according to whether cases not proved microbiologically are included or excluded. The incidence rate for all cases of candidosis is calculated to be 50 9 per 1000, for trichomoniasis 10.1 per 1000, and for gonorrhoea 6-2 per 1000. If the calculation is limited only to microbiologically proved cases the rates naturally decrease. Thus for candida the incidence rate is 11 0 per 1000, for trichomoniasis 7-7 per 1000, and for gonorrhoea 5-0 per 1000.
Prevalence
The prevalence of disease may be calculated from the cases found in women who were not seeking care for genital symptoms when screened.
All the cases included in the estimates of prevalence were proved microbiologically. In contrast to the incidence rates, however, which were calculated by summing cases diagnosed in women consulting at various agencies, the prevalence rates could have been biased since they are based solely on cases identified at screening, and rest on the assumption that the women who participated were representative of the female population of Brent and Harrow. Comparisons between the distributions of age and marital state among patients sampled in the different agencies and those in the female population of Brent and Harrow confirmed that they were significantly different. The prevalence rates for candidosis were therefore standardised by age, since this condition was found to be related to age (patients with the condition were younger than those without), while the rates for trichomoniasis were standardised by marital state (more single patients suffered from the condition). No standardisation was performed for gonorrhoea since there were too few cases. Calculation of overall population prevalence rates for the three diseases was not thought to be justified, since the weights that would have to be assigned to each component rate are unknown. Table II shows numbers of women screened in general practice and antenatal, gynaecology, and family planning clinics and the numbers of positive diagnoses. Of the 555 women examined in gynaecology clinics, 480 were referred for symptoms unrelated to sexually transmitted disease and are therefore included in the calculation of prevalence. None of the women screened in antenatal and family planning clinics were attending because of genital symptoms. The prevalence of the three conditions varies among agencies: for candidosis the highest rates were found in general practice and antenatal clinics; for trichomoniasis the highest rate was in gynaecological patients with lower but similar rates in antenatal and family planning patients. No cases of gonorrhoea were identified in general practice or family planning clinics. The prevalence rates among antenatal and gynaecological patients were similar, although the latter was the higher.
Discussion
The incidence and prevalence of three diseases have been reported. In our study both rates were highest for candidosis, particularly among general practice patients. In view of the poor discriminating power of genital symptoms women in whom candidosis is diagnosed and treated empirically may, in fact, be suffering from trichomoniasis or gonorrhoea, or both."12 Given that candidosis is considerably more common, how should general practitioners manage women presenting with genital symptoms ? One approach is to advise practitioners that all such women be referred to a sexually transmitted diseases clinic for full microbiological tests or that these are done by the practitioner in the surgery. The strategy of referring all patients with genital symptoms to clinics may be desirable, but it is not practicable. It would result in extensive increases in clinic work load, the diagnosis of candidosis, and the attendance of low-risk women. A more pragmatic strategy would be for general practitioners to take accurate sexual histories in an attempt to identify high-risk individuals (recent partner change, multiple sexual contacts, recurrent or persistent symptoms, and symptoms in sexual partners). These patients could then be referred for specialist advice. The remaining patients could be treated empirically for candidosis. This strategy, however, should be followed only if the patient is advised to return, so that persistent symptoms may be fully investigated in the practice or a clinic to exclude trichomoniasis and gonorrhoea. Additionally, since gonorrhoea is always and trichomoniasis usually spread by sexual intercourse, male contacts need to be traced, investigated, and treated.
The other question to be answered is whether the findings of this study indicate the existence of such a substantial amount of undetected and untreated disease that alterations in strategy for controlling sexually transmitted diseases are required. The incidence rates calculated in this study take into account patients who have sought treatment for a potential sexually transmitted disease. It is therefore more important to consider the prevalence rates, which are largely contributed by asymptomatic women who, since they do not consult, remain outside the medical care system. The rates and clinical importance, however, of the three diseases differ considerably. The prevalence of gonorrhoea was either zero or under five per 1000 in the different agencies sampled. Although this is the most serious of the three diseases in terms of complications and infectivity, such low rates hardly justify wide-scale screening for this condition among women attending general practice, antenatal, gynaecology, and family planning clinics.
The prevalence rates for trichomoniasis were higher than for gonorrhoea and varied among clinics: gynaecology (70 per 1000), family planning (47), antenatal (44), and general practice (32). Consideration needs to be given to whether this is sufficiently common to recommend screening all women for trichomoniasis. In numerical terms these rates appear high, but the decision to screen depends largely on the consequences of non-treatment and the ease with which screening can be carried out. Even though the symptoms of trichomonal infection can be severe, the disease is not serious since salpingitis, metastatic complications, and fetal infection do not occur. Establishing the diagnosis by the dark ground examination of a wet preparation of material taken from the posterior fornix is relatively easy. Given the frequency with which this disease was found among women sampled in hospital, particularly in gynaecology clinics, and the ease of immediate microscopic diagnosis, it is probably justifiable to look for this condition in all women attending antenatal, gynaecology, and hospital family planning clinics.
The prevalence rates for candidosis were the highest of the three diseases. Many women with this condition are asymptomatic. Since there is still controversy about the appropriateness of treating asymptomatic candidosis, and the disease has no serious complications, screening is not recommended."
The sample of women studied was unselected in that it was drawn from several different agencies, and from those who had and had not sought care. Those studied, however, are not necessarily representative of women of similar ages in the rest of the United Kingdom or Brent and Harrow. Studies in other parts of the country would be required to estimate national incidence and prevalence rates. The problem caused by dcfferences found in terms of age and marital state between the study patients and the Brent and Harrow population from which they were drawn was partially solved by the standardisation carried out. Nevertheless, this does not overcome the bias potentially caused by the low response rate in one part of the study (general practice screening). Experience from other screening surveys, such as for cervical cytology, suggest that disease or abnormalities are higher in non-respondents.15 Thus our rates may be slightly low.
The findings of this study would suggest that wide-scale screening for gonorrhoea is not justified but that limited screening for trichomoniasis within the context of antenatal, gynaecology, and hospital family planning clinics should be encouraged. The decision not to screen for gonorrhoea should be taken only if two criteria are fulfilled. Firstly, good comprehensive facilities for contact tracing must exist so that asymptomatic women not seeking care will be examined, and, secondly, general practitioners engaging in empirical treatment without microbiological support should follow up all their patients thus treated to ensure that trichomoniasis and gonorrhoea are not present, and that subsequent microbiological tests and contact tracing are performed.
